- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Geneviève Michaux
Events 20 results
Webinar
April 23, 2026
AI in EU Pharma: Navigating Efficiency, Innovation and Regulatory Challenges
Speaking Engagement
April 2, 2026
Christina Markus and Geneviève Michaux to Speak at two European Cell and Gene Therapy Research Consortia
Webinar
March 12, 2026
Key Revisions of the EU General Pharmaceutical Legislation
Webinar
January 29, 2026
The Revision of the EU General Pharmaceutical Legislation
Webinar
November 20, 2025
Pricing and Reimbursement in Europe
Conference
November 13, 2025
Medical Device Forum
Conference
November 4, 2025
King & Spalding Pharmaceutical University 2025
Webinar
October 23, 2025
Interactions with HCPs, Anti-Kickbacks and Transparency
Webinar
September 17, 2025
Advertising and Promotion of Medicinal Products
Conference
September 4, 2025
18th Annual King & Spalding Medical Device Summit
Webinar
June 26, 2025
Manufacturing, Distribution, and Shortages
Webinar
April 10, 2025
Combination, Personalized, and Advanced Therapy Medicinal Products